With institutional ethical approval (Faculty of Medicine, University of Toronto, Canada) and having obtained written informed consent, we plan to recruit 40 patients, aged 18-75, ASA I-III scheduled to undergo unilateral total knee arthroplastly in this prospective, randomised, single blinded controlled trial.